Scleroderma systematica concurrent with neoplasm

Scleroderma systematica concurrent with neoplasm

Saved in:

Bibliographic Details
Main Authors:	Maya Nikolayevna Starovoitova, N G Guseva, O V Desinova
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2011-06-01
Series:	Научно-практическая ревматология
Online Access:	https://rsp.mediar-press.net/rsp/article/view/716
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Skin lesion in scleroderma systematica
by: Maya Nikolayevna Starovoitova
Published: (2010-04-01)

COMPLEX THERAPY FOR VASCULAR DISORDERS IN PATIENTS WITH SCLERODERMA SYSTEMATICA
by: M N Starovoitova, et al.
Published: (2009-06-01)

RITUXIMAB TREATMENT FOR INTERSTITIAL LUNG INJURY IN SCLERODERMA SYSTEMATICA
by: Lidia Petrovna Ananieva, et al.
Published: (2013-12-01)

A case of osteopoikilia in a female patient with scleroderma systematica
by: Ekaterina Nikolayevna Sukhikh, et al.
Published: (2013-06-01)

Experience in using actovegin for focal scleroderma
by: Mayya Nikolaevna Starovoytova, et al.
Published: (2011-09-01)

SCLERODERMA SYSTEMATICA WITH INTERSTITIAL LUNG LESION: COMPARATIVE CLINICAL CHARACTERISTICSWITH PATIENTS WITHOUT LUNG LESION
by: Lyudmila Valeryevna Teplova, et al.
Published: (2010-06-01)

Use of the international systemic scleroderma activity index
by: Maya Nikolayevna Starovoitova, et al.
Published: (2013-03-01)

The problem of activity in systemic scleroderma
by: N G Guseva, et al.
Published: (2013-06-01)

DIAGNOSIS OF PULMONARY HYPERTENSION IN SCLERODERMA SYSTEMATICA
by: A V Volkov, et al.
Published: (2008-12-01)

UNILATERAL LUNG INJURY IN SCLERODERMA SYSTEMATICA: A CASE REPORT
by: R. T. Alekperov, et al.
Published: (2014-09-01)

ESOPHAGEAL PATHOLOGY IN SCLERODERMA SYSTEMATICA: CLINICAL AND ENDOSCOPIC FINDINGS
by: A E Karateev, et al.
Published: (2012-02-01)

Diagnosis and treatment of interstitial lung disease in scleroderma systematica
by: L. P. Ananyeva
Published: (2018-06-01)

NEW CLASSIFICATION CRITERIA FOR SCLERODERMA SYSTEMATICA (a lecture)
by: Lidia Petrovna Ananyeva
Published: (2013-12-01)

Assessment of lung ultrasound in patients with scleroderma systematica and interstitial lung disease
by: Olga Borisovna Ovsyannikova, et al.
Published: (2013-06-01)

Positivity for antiribonucleoprotein antibodies in rheumatic diseases: focus on scleroderma systematica
by: R. U. Shayakhmetova, et al.
Published: (2018-01-01)

Microcirculatory disorders in scleroderma systematica: an association with vascular wall stiffness
by: Ulyana Yuryevna Ruzhentsova
Published: (2013-06-01)

Therapy for digital ulcers in patients with systemic scleroderma
by: M. N. Starovoitova, et al.
Published: (2019-01-01)

Fibrosing arthropathy in juvenile scleroderma
by: D. A. Dibrov, et al.
Published: (2021-04-01)

Scleromyxedema concurrent with dermatomyositis and paraproteinemia: A case report
by: M. N. Starovoitova, et al.
Published: (2015-03-01)

IMPORTANCE OF CYCLOPHOSPHANUM IN THE TREATMENT OF INTERSTITIAL LUNG LESION IN PATIENTS WITH SCLERODERMA SYSTEMATICA (A REVIEW OF LITERATURE)
by: Olga Aleksandrova Koneva
Published: (2010-06-01)

ULTRASOUND SCANNING: POSSIBILITIES AND PROSPECTS OF EVALUATING LUNG INVOLVEMENT IN SYSTEMIC SCLERODERMA
by: Olga Borisovna Ovsyannikova, et al.
Published: (2012-12-01)

Systemic scleroderma is a multidisciplinary problem
by: N G Guseva, et al.
Published: (2011-04-01)

SUBTYPES OF JUVENILE SYSTEMIC SCLERODERMA
by: M N Slarovoitova, et al.
Published: (2001-04-01)

STUDY OF THE EFFICIENCY AND SAFETY OF MYCOPHENOLATE MOFETIL THERAPY IN PATIENTSWITH SYSTEMIC SCLERODERMA
by: O A Koneva, et al.
Published: (2011-08-01)

Immunological features in anti-U1-ribonucleoprotein antibody positive patients with systemic scleroderma
by: R. U. Shayakhmetova, et al.
Published: (2020-03-01)

CLINICAL IMPORTANCE OF INTERLEUKIN-4 IN SYSTEMIC SCLERODERMA
by: T A Nevskaya, et al.
Published: (2002-02-01)

CLINICAL EVALUATION OF THE MANIFESTATIONS OF INTERSTITIAL LUNG INJURYIN SYSTEMIC SCLERODERMA FROM HIGH-RESOLUTION COMPUTER T OMOGRAPHY DATA
by: L P Anan'eva, et al.
Published: (2011-04-01)

The use of the Scleroderma Clinical Trials Consortium Damage Index in systemic sclerosis
by: L. P. Ananyeva, et al.
Published: (2025-03-01)

Scleroderma as a paraneoplastic syndrome and tumors associated with scleroderma
by: N. A. Shostak, et al.
Published: (2020-05-01)

Scleroderma-panniculitis: view of the rheumatologist
by: A. S. Potapova, et al.
Published: (2021-04-01)

Scleroderma Renal Crisis as Initial Presentation of Scleroderma
by: Sahil Bagai, et al.
Published: (2022-04-01)

Assessment of concurrent neoplasms and a paraneoplastic association in MOGAD
by: Young Nam Kwon, et al.
Published: (2025-04-01)

DIFFERENTIAL DIAGNOSIS IN JUVENILE SCLERODERMA
by: M.K. Osminina, et al.
Published: (2008-01-01)

Mimics of scleroderma
by: Kaveri K Nalianda, et al.
Published: (2017-01-01)

Bone mineral density in patients with systemic scleroderma
by: O. V. Dobrovolskaya, et al.
Published: (2019-03-01)

SCLERODERMA-LIKE MASK OF OSTEOPOIKILIA
by: R G Mukhina, et al.
Published: (2002-04-01)

Treatment for systemic scleroderma
by: Rezvaya Tairovich Alekperov, et al.
Published: (2011-09-01)

GI Manifestation in Scleroderma
by: Chingching Foocharoen
Published: (2024-01-01)

Thelytoky in Scleroderma Immigrans
by: Clyde E. Keeler
Published: (1929-01-01)

DIAGNOSTIC VALUE OF CERULOPLASMIN IN SYSTEMIC SCLERODERMA
by: O. I. Emelyanova, et al.
Published: (2019-05-01)